Scalable Stirred-suspension Bioreactor Culture of Human Pluripotent Stem Cells

Overview

Journal Tissue Eng Part A

Specialties Anatomy & Histology
Biomedical Engineering
Biotechnology

Date 2009 Sep 11

PMID 19739936

Citations 86

Authors

Daniel E Kehoe

Donghui Jing

Lye T Lock

Emmanuel S Tzanakakis

Affiliations

Soon will be listed here.

Abstract

Advances in stem cell biology have afforded promising results for the generation of various cell types for therapies against devastating diseases. However, a prerequisite for realizing the therapeutic potential of stem cells is the development of bioprocesses for the production of stem cell progeny in quantities that satisfy clinical demands. Recent reports on the expansion and directed differentiation of human embryonic stem cells (hESCs) in scalable stirred-suspension bioreactors (SSBs) demonstrated that large-scale production of therapeutically useful hESC progeny is feasible with current state-of-the-art culture technologies. Stem cells have been cultured in SSBs as aggregates, in microcarrier suspension and after encapsulation. The various modes in which SSBs can be employed for the cultivation of hESCs and human induced pluripotent stem cells (hiPSCs) are described. To that end, this is the first account of hiPSC cultivation in a microcarrier stirred-suspension system. Given that cultured stem cells and their differentiated progeny are the actual products used in tissue engineering and cell therapies, the impact of bioreactor's operating conditions on stem cell self-renewal and commitment should be considered. The effects of variables specific to SSB operation on stem cell physiology are discussed. Finally, major challenges are presented which remain to be addressed before the mainstream use of SSBs for the large-scale culture of hESCs and hiPSCs.

Citing Articles

Advancements in osteoblast sourcing, isolation, and characterization for dental tissue regeneration: a review.

Venkataiah V, Mehta D, Fareed M, Karobari M Biomed Eng Online. 2025; 24(1):31.

PMID: 40057736 PMC: 11890725. DOI: 10.1186/s12938-025-01363-y.

Cell Adhesion and Local Cytokine Control on Protein-Functionalized PNIPAM-co-AAc Hydrogel Microcarriers.

Rauer S, Stuwe L, Steinbeck L, de Toledo M, Fischer G, Wennemaring S Small. 2024; 21(2):e2404183.

PMID: 39535368 PMC: 11735893. DOI: 10.1002/smll.202404183.

Complete suspension culture of human induced pluripotent stem cells supplemented with suppressors of spontaneous differentiation.

Matsuo-Takasaki M, Kambayashi S, Hemmi Y, Wakabayashi T, Shimizu T, An Y Elife. 2024; 12.

PMID: 39529479 PMC: 11556790. DOI: 10.7554/eLife.89724.

Designing magnetic microcapsules for cultivation and differentiation of stem cell spheroids.

Gwon K, Dharmesh E, Nguyen K, Schornack A, de Hoyos-Vega J, Ceylan H Microsyst Nanoeng. 2024; 10(1):127.

PMID: 39261472 PMC: 11390961. DOI: 10.1038/s41378-024-00747-9.

Robust bioprocess design and evaluation of commercial media for the serial expansion of human induced pluripotent stem cell aggregate cultures in vertical-wheel bioreactors.

Borys B, Dang T, Worden H, Larijani L, Corpuz J, Abraham B Stem Cell Res Ther. 2024; 15(1):232.

PMID: 39075528 PMC: 11288049. DOI: 10.1186/s13287-024-03819-9.

References

Cherry R, Papoutsakis E . Physical mechanisms of cell damage in microcarrier cell culture bioreactors. Biotechnol Bioeng. 1988; 32(8):1001-14. DOI: 10.1002/bit.260320808. View

Yener B, Acar E, Aguis P, Bennett K, Vandenberg S, Plopper G . Multiway modeling and analysis in stem cell systems biology. BMC Syst Biol. 2008; 2:63. PMC: 2527292. DOI: 10.1186/1752-0509-2-63. View

Cherry R, Kwon K . Transient shear stresses on a suspension cell in turbulence. Biotechnol Bioeng. 1990; 36(6):563-71. DOI: 10.1002/bit.260360603. View

Hwang Y, Cho J, Tay F, Heng J, Ho R, Kazarian S . The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials. 2008; 30(4):499-507. DOI: 10.1016/j.biomaterials.2008.07.028. View

Kamei K, Guo S, Yu Z, Takahashi H, Gschweng E, Suh C . An integrated microfluidic culture device for quantitative analysis of human embryonic stem cells. Lab Chip. 2009; 9(4):555-63. DOI: 10.1039/b809105f. View

DAmour K, Bang A, Eliazer S, Kelly O, Agulnick A, Smart N . Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006; 24(11):1392-401. DOI: 10.1038/nbt1259. View

Saha S, Ji L, de Pablo J, Palecek S . Inhibition of human embryonic stem cell differentiation by mechanical strain. J Cell Physiol. 2005; 206(1):126-37. DOI: 10.1002/jcp.20441. View

Papoutsakis E . Fluid-mechanical damage of animal cells in bioreactors. Trends Biotechnol. 1991; 9(12):427-37. DOI: 10.1016/0167-7799(91)90145-8. View

Yirme G, Amit M, Laevsky I, Osenberg S, Itskovitz-Eldor J . Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev. 2008; 17(6):1227-41. DOI: 10.1089/scd.2007.0272. View

10.

Wu X, Walker J, Zhang J, Ding S, Schultz P . Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chem Biol. 2004; 11(9):1229-38. DOI: 10.1016/j.chembiol.2004.06.010. View

11.

Huang P, Hellums J . Aggregation and disaggregation kinetics of human blood platelets: Part II. Shear-induced platelet aggregation. Biophys J. 1993; 65(1):344-53. PMC: 1225729. DOI: 10.1016/S0006-3495(93)81079-8. View

12.

Papoutsakis E . Media additives for protecting freely suspended animal cells against agitation and aeration damage. Trends Biotechnol. 1991; 9(9):316-24. DOI: 10.1016/0167-7799(91)90102-n. View

13.

Cowan C, Atienza J, Melton D, Eggan K . Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005; 309(5739):1369-73. DOI: 10.1126/science.1116447. View

14.

Michaels J, Mallik A, Papoutsakis E . Sparging and agitation-induced injury of cultured animals cells: Do cell-to-bubble interactions in the bulk liquid injure cells?. Biotechnol Bioeng. 1996; 51(4):399-409. DOI: 10.1002/(SICI)1097-0290(19960820)51:4<399::AID-BIT3>3.0.CO;2-D. View

15.

Li L, Baroja M, Majumdar A, Chadwick K, Rouleau A, Gallacher L . Human embryonic stem cells possess immune-privileged properties. Stem Cells. 2004; 22(4):448-56. DOI: 10.1634/stemcells.22-4-448. View

16.

Moreira J, Santana P, Feliciano A, Cruz P, Racher A, Griffiths J . Effect of viscosity upon hydrodynamically controlled natural aggregates of animal cells grown in stirred vessels. Biotechnol Prog. 1995; 11(5):575-83. DOI: 10.1021/bp00035a012. View

17.

Martin-Ibanez R, Unger C, Stromberg A, Baker D, Canals J, Hovatta O . Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Hum Reprod. 2008; 23(12):2744-54. DOI: 10.1093/humrep/den316. View

18.

McQueen A, Meilhoc E, Bailey J . Flow effects on the viability and lysis of suspended mammalian cells. Biotechnol Lett. 2017; 9(12):831-836. DOI: 10.1007/BF01026191. View

19.

Fischer B, Bavister B . Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil. 1993; 99(2):673-9. DOI: 10.1530/jrf.0.0990673. View

20.

Draper J, Smith K, Gokhale P, Moore H, Maltby E, Johnson J . Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2003; 22(1):53-4. DOI: 10.1038/nbt922. View